Alerts will be sent to your verified email
Verify Email
SHILPAMED
|
Shilpa Medicare
|
Aarti Pharmalabs
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.0 % | 9.05 % | 29.47 % |
|
5yr Avg Net Profit Margin
|
7.72 % | 8.95 % | 24.83 % |
|
Price to Book
|
3.5 | 3.9 | 5.35 |
|
P/E
|
74.66 | 29.14 | 29.95 |
|
5yr Avg Cash Conversion Cycle
|
76.54 Days | 94.46 Days | 10.2 Days |
|
5yr Average Interest Coverage Ratio
|
11.52 | 12.05 | 36.33 |
|
5yr Avg ROCE
|
6.65 % | 12.13 % | 37.03 % |
|
5yr Avg Operating Profit Margin
|
17.76 % | 15.5 % | 34.97 % |
|
5 yr average Debt to Equity
|
0.44 | 0.16 | 0.17 |
|
5yr CAGR Net Profit
|
-27.23 % | n/a | 10.17 % |
|
5yr Average Return on Assets
|
3.1 % | 6.11 % | 18.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.23 % | 43.72 % | 68.3 % |
|
Share Pledged by Promoters
|
7.92 % | 0.01 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.78 % | -2.26 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.04 % | -4.21 % | -2.44 % |
|
Shilpa Medicare
|
Aarti Pharmalabs
|
Supriya Lifescience
|
|---|